- FDA Approves Eisai and Biogen’s New Alzheimer’s Therapy (barrons)
- The Dow Soars 700 Points as Wage Growth Slows (barrons)
- The Case for Holding—Not Selling—GE’s Healthcare Spinoff (barrons)
- Salesforce co-CEO Marc Benioff hints at more potential layoffs after this week’s job cuts (cnbc)
- Semiconductor Companies are Struggling. A Bottom Could Be Nearer. (barrons)
- New Chinese mRNA Covid vaccine shows positive early results (ft)
- Jack Ma Is Spotted in Thailand in a Rare Public Appearance (bloomberg)
- What stock-market investors need to know about the ‘January Indicator Trifecta’ (marketwatch)
- History shows odds favor a 20% stock-market return in 2023 after a brutal 2022, Fundstrat says (marketwatch)
- Treasury yields plunge on raft of U.S. data, handing 30-year rate biggest weekly decline since March 2020 (marketwatch)
- CrowdStrike Stock Has Tumbled. One Director Scooped Up Shares. (barrons)
- Tesla’s Battered Stock Looks Like a Buy Again (barrons)
- What China’s reopening means for markets, according to Goldman Sachs (marketwatch)
- Goldilocks scenario? Slower increases in worker wages could help U.S. economy avert a recession. (marketwatch)
- Snowflake Is a Great Cloud Stock to Buy on the Dip, Says Wells Fargo (barrons)
- China Stock Traders Bet Consumption Will Supercharge 2023 Rally (bloomberg)
- Goldilocks Makes an Appearance in the Jobs Market (bloomberg)
- The $350,000 Mercedes-AMG G63 4×4² Is an Unapologetic Joy Ride (bloomberg)
- ‘Avatar 2’ Beats ‘Top Gun’ Sequel With $1.5 Billion in Global Sales (bloomberg)
- From Miami to Manhattan, the 14 Most Anticipated Restaurants in America (bloomberg)
- Signs of Seller Exhaustion Left Stocks Primed for a Big Bounce (bloomberg)
- China Stock Traders Bet Consumption Will Supercharge 2023 Rally (bloomberg)
- Jack Ma Is Spotted in Thailand in a Rare Public Appearance (bloomberg)
- Bill Miller doubles down on Amazon after a rough year, while shorting Tesla increasingly (cnbc)
- CES 2023: What we learned about the cars of the future (usatoday)
- Why Does Private Equity Get to Play Make-Believe With Prices? (institutionalinvestor)
- 33 Undervalued Stocks for Q1 2023 (morningstar)